Hemodynamics, fluids & transfusion

Desmopressin to reduce periprocedural bleeding and transfusion: a systematic review and meta-analysis

Perioper Med (Lond)Published Systematic review and meta-analysis of randomised trials

Pooled result · RBC transfusionResult — go to the resultRelative risk 0.95 95% CI 0.86–1.05

Authors' conclusion

In conclusion, desmopressin likely reduces periprocedural blood loss and the number of units of blood transfused in small trials with methodologic limitations.

Study context

Population
Patients without known inherited bleeding disorders undergoing surgery or other invasive procedures (38 trials cardiac surgery, 22 noncardiac surgery, 3 non-surgical procedures)
Participants
4,163 patients · 63 RCTs
Comparison
Peri-procedural desmopressin vs placebo or usual care
Outcome
RBC transfusion
Methodological detailsLiterature up to February 1, 2023
  • Literature up to February 1, 2023

Pooled result

As reported in the abstract

Relative risk

0.95

95% CI 0.86–1.05

Desmopressin vs Placebo or usual care
RR 0.95 (95% CI 0.86–1.05)

Further pooled results

OutcomeRR (95% CI)
Reoperation due to bleeding22 trials · may not reduce risk0.75 (0.47–1.19)
Bleeding events2 trials · certainty of evidence generally low0.45 (0.24–0.84)
Transfusion risk, desmopressin vs TXA3 trials; favoring TXA · limited evidence2.38 (1.06–5.39)
OutcomeMD (mL) (95% CI)
Total volume of blood loss, desmopressin vs TXA3 trials; favoring TXA · limited evidence391.7 (- 93.3 to 876.7)
OutcomeEstimate
Number of units of RBC transfused25 trials · certainty of evidence generally lowMD −0.55 units (95% CI - 0.94 to - 0.15)
Total volume of blood loss33 trials · certainty of evidence generally lowSMD - 0.40 standard deviations (95% CI - 0.56 to - 0.23)

Safety

OutcomeRR (95% CI)
Clinically significant hypotension requiring intervention19 trials2.15 (1.36–3.41)

Original publication

Desmopressin to reduce periprocedural bleeding and transfusion: a systematic review and meta-analysis. Perioper Med (Lond). Published 23 January 2024. doi:10.1186/s13741-023-00358-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.